Bristol-Myers Squibb (NYSE:BMY) recently gained European Commission approval for Breyanzi, broadening treatment options for ...

We recently published a list of Friday’s 10 Worst Performing Stocks. In this article, we are going to take a look at where ...

Bristol Myers Squibb Co. closed 6.82% below its 52-week high of $63.33, which the company reached on March 11th.

EC approves BMY's Breyanzi for relapsed or refractory FL, based on Phase 2 study showing high response rates & sustained ...

The S&P 500 jumped 2.1% on Friday, March 14, wrapping up a volatile week as government shutdown concerns eased.

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

Eric Stonestreet, who played Cam Tucker on "Modern Family," has had a successful career, but it's been punctuated by a number ...

The EC approved the CAR T-cell therapy based on data from a Phase II study showing a 94 percent complete response rate.

The firms expect that by expanding manufacturing capacity they can double the sales volume of Carvykti from 10,000 doses in 2025 to 20,000 doses in 2027.

During a Case-Based Roundtable® event, Vamsidhar Velcheti, MD, discussed the TRIDENT-1 trial and practical considerations for ...

Major indices closed higher on Friday in what had otherwise been a losing week for the Dow Jones. At the close, the Dow Jones ...